$22.34+0.03 (+0.13%)
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.
Tactile Systems Technology, Inc. in the Healthcare sector is trading at $22.34 with a market capitalization of $510M. Wall Street consensus targets $37.67 (3 analysts), implying a +68.6% move over the next 12 months. The stock is currently 41% below its 52-week high of $37.77, remaining 14.9% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $85.70Mβ | $75.27Mβ | $103.59Mβ | $85.75Mβ | $78.91M |
| Gross Profit | $65.35Mβ | $57.61Mβ | $81.01Mβ | $65.00Mβ | $58.79M |
| Operating Income | $6.83Mβ | -$1.53Mβ | $18.77Mβ | $10.96Mβ | $4.08M |
| Net Income | $7.79Mβ | -$1.76Mβ | $10.63Mβ | $8.21Mβ | $3.22M |
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of ly...